Globalseo is still translating this page... (closing in 5s)
Skip to main content

5-methyltetrahydrofolate-homocysteine methyltransferase

The MTR gene provides instructions for making an enzyme called methionine synthase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Specifically, methionine synthase carries out a chemical reaction that converts the amino acid homocysteine to another amino acid called methionine. The body uses methionine to make proteins and other important compounds. To function properly, methionine synthase requires methylcobalamin (a form of vitamin B12) and another enzyme called methionine synthase reductase, which is produced from the MTRR gene.

Normal function

The MTR gene provides instructions for making an enzyme called methionine synthase. This enzyme plays a role in processing amino acids, the building blocks of proteins. Specifically, methionine synthase carries out a chemical reaction that converts the amino acid homocysteine to another amino acid called methionine. The body uses methionine to make proteins and other important compounds. To function properly, methionine synthase requires methylcobalamin (a form of vitamin B12) and another enzyme called methionine synthase reductase, which is produced from the MTRR gene.

Conditions referring to this gene or chromosome

Other names

5-methyltetrahydrofolate-homocysteine methyltransferase 1

5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase

cblG

cobalamin-dependent methionine synthase

Homocysteine-methyl tetrahydrofolate methyltransferase

METH_HUMAN

Methionine Synthase

Tetrahydropteroylglutamate Methyltransferase

Related patient information and medicines

Kawasaki disease

Patient information leaflet

Kawasaki disease

Kawasaki disease is a rare condition that affects small to medium-sized blood vessels in the body. Kawasaki disease causes the the walls of the blood vessels to become inflamed and swollen (vasculitis). Kawasaki disease mainly affects children less than 5 years old. The exact cause of Kawasaki disease remains unknown. Kawasaki disease causes a.

Travelling to remote locations

Patient information leaflet

Travelling to remote locations

It is so that if you seek medical help from doctors and nurses in the country where you are travelling, they can advise you wha... Self-treatment is a last resort as it is very difficult for anyone to make treatment decisions about themselves. Reference book Pocket First Aid and Wilderness Medicine: Drs Jim Duff and Peter Gormly (2010). This is an.

Parkinson's disease

Patient information leaflet

Parkinson's disease

Parkinson's disease is a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement disorder with Parkinson's disease symptoms. The National Institute for Health and Care Excellence (NICE) has just approved a few devices.

Macrocytosis and macrocytic anaemia

Patient information leaflet

Macrocytosis and macrocytic anaemia

Macrocytosis refers to red blood cells which are larger than normal. It does not cause any symptoms in itself. Macrocytosis symptoms You may also find relevant information in our other separate leaflet called What is blood. Macrocytosis can exist without anaemia. Macrocytosis itself does not cause any symptoms but can be a sign of low levels of.

Acute pancreatitis

Patient information leaflet

Acute pancreatitis

It is occasionally possible to have acute pancreatitis without any pain; this is more common in people with diabetes or kidney problems. Being sick (vomiting). A high temperature (fever) and generally feeling very unwell are common. Swollen abdomen. If the pancreatitis becomes severe and other organs become involved (for example, the heart, lungs.

Polycystic kidney disease

Patient information leaflet

Polycystic kidney disease

Polycystic kidney disease (PKD) causes many fluid-filled sacs (cysts) to develop in the kidneys. The most common type of PKD is an inherited condition called autosomal dominant polycystic kidney disease (ADPKD). With ADPKD, problems commonly do not develop until the age of 30-50, with some people never developing any problems. About half of ADPKD.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 8 May 2023 | Latest version
  • 1 Jul 2011 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
flu eligibility checker

Ask, share, connect.

Browse discussions, ask questions, and share experiences across hundreds of health topics.

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.